Skip to content
10-Q

Quarterly Report

OCEAN BIOMEDICAL, INC. OCEA

0001641172-25-011080

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 15, 2025 232.37M sh
Shares Diluted Q1 2025 · Mar 31, 2025 91.02M sh
Shares Diluted Q1 2025 · Mar 31, 2024 27.34M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$356K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$485K
Stockholders Equity Q1 2025 · Mar 31, 2025 −$92.4M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$97.62M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$75.78M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$90.76M
Current Liabilities Q1 2025 · Mar 31, 2025 $26.57M
Current Liabilities Q1 2025 · Dec 31, 2024 $33.89M
Total Liabilities Q1 2025 · Mar 31, 2025 $93.98M
Total Liabilities Q1 2025 · Dec 31, 2024 $98.52M
Current Assets Q1 2025 · Mar 31, 2025 $1.49M
Current Assets Q1 2025 · Dec 31, 2024 $812K
Total Assets Q1 2025 · Mar 31, 2025 $1.58M
Total Assets Q1 2025 · Dec 31, 2024 $902K
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.09
Eps Diluted Q1 2025 · Mar 31, 2024 $0.48
Eps Basic Q1 2025 · Mar 31, 2025 −$0.09
Eps Basic Q1 2025 · Mar 31, 2024 $0.48
Sga Expense Q1 2025 · Mar 31, 2025 $940K
Sga Expense Q1 2025 · Mar 31, 2024 $569K
Rd Expense Q1 2025 · Mar 31, 2025 $18K
Rd Expense Q1 2025 · Mar 31, 2024 $26K
Net Income Q1 2025 · Mar 31, 2025 −$8.24M
Net Income Q1 2025 · Mar 31, 2024 $13M
Operating Income Q1 2025 · Mar 31, 2025 −$958K
Operating Income Q1 2025 · Mar 31, 2024 −$595K